New York City | United States
| Investor Type | Firm |
| Type of Fund | Private Equity Fund |
| Industries | Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Hardware (& Manufacturing) • HealthTech (& Fitness) • Cannabis • Cloud Services (& Infrastructure) • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Consumer • Pharmaceutical (& Medicine) • Diagnostics |
| Stages | Seed, Series B, Series A |
| Investing | United States • United Kingdom • Canada • China • Switzerland |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
| Assets Under Management | $280,000,000 |
What is Aisling Capital?
Aisling Capital is a venture capital and private equity firm that focuses on investments in the healthcare and life sciences sectors. Since its inception in 2000, Aisling Capital has been targeting companies that operate within products, technology, global business, and life sciences domains. They position themselves as a key player in funding companies that have the potential to lead and transform the industry.
With an emphasis on Software, IT & TMT, Biotech, Hardware & Manufacturing, HealthTech & Fitness, Cloud Services & Infrastructure, Material Science, Medical Devices & Hospital Services, Healthcare & Wellness, Life Science, and Consumer sectors, they provide the necessary capital and support for growth and innovation.
Aisling Capital operates with a minimum investment threshold of $100,000 and can invest up to $5,000,000, with a sweet spot at approximately $1,500,000 for investments.
Their investment strategy is not confined to a single phase of a company's development; instead, they are known for their versatility in investment stages, which includes Seed, Series A, and Series B rounds. The firm manages assets totaling $280,000,000, leveraging this substantial capital base to foster the next generation of groundbreaking companies at various growth stages.
Aisling Capital's aim is to partner with companies to advance scientific and technological innovation, which they believe is key to improving patient outcomes and delivering valuable healthcare solutions.
What they say:
We foresee a transformative decade for healthcare, propelled by the development of novel therapeutics.
What we look for: We invest in biotech, healthcare, therapeutics.
What are the investment firms similar to Aisling Capital
Athyrium Capital Management
OrbiMed
Muzinich & Co
BVM Capital
Petrichor Healthcare Capital Management
Exsight Ventures
Hippocrates Ventures
Cormorant Capital
Dome Equities
Think3
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 71-75 Shelton Street, Covent Garden, WC2H 9JQ
- London, U.K.
- contact@angelspartners.com
